IceCube expectations for two high-energy neutrino production models at active galactic nuclei

We have determined the currently allowed regions of the parameter spaces of two representative models of diffuse neutrino flux from active galactic nuclei (AGN): one by Koers & Tinyakov (KT) and another by Becker & Biermann (BB). Our observable has been the number of upgoing muon-neutrinos expected in the 86-string IceCube detector, after 5 years of exposure, in the range 10^5 < E/GeV < 10^8. We have used the latest estimated discovery potential of the IceCube-86 array at the 5-sigma level to determine the lower boundary of the regions, while for the upper boundary we have used either the AMANDA upper bound on the neutrino flux or the more recent preliminary upper bound given by the half-completed IceCube-40 array (IC40). We have varied the spectral index of the proposed power-law fluxes, alpha, and two parameters of the BB model: the ratio between the boost factors of neutrinos and cosmic rays, Gamma_nu/Gamma_{CR}, and the maximum redshift of the sources that contribute to the cosmic-ray flux, zCRmax. For the KT model, we have considered two scenarios: one in which the number density of AGN does not evolve with redshift and another in which it evolves strongly, following the star formation rate. Using the IC40 upper bound, we have found that the models are visible in IceCube-86 only inside very thin strips of parameter space and that both of them are discarded at the preferred value of alpha = 2.7 obtained from fits to cosmic-ray data. Lower values of alpha, notably the values 2.0 and 2.3 proposed in the literature, fare better. In addition, we have analysed the capacity of IceCube-86 to discriminate between the models within the small regions of parameter space where both of them give testable predictions. Within these regions, discrimination at the 5-sigma level or more is guaranteed.Comment: 24 pages, 6 figures, v2: new IceCube-40 astrophysical neutrino upper bound and IceCube-86 discovery potential used, explanation of AGN flux models improved, only upgoing neutrinos used, conclusions strengthened. Accepted for publication in JCA

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems

Quantificação de fatores de crescimento na pele de equinos tratada com plasma rico em plaquetas

O plasma rico em plaquetas (PRP) é um produto derivado da centrifugação do sangue total, sendo rico em fatores bioativos, como os de crescimento. Apesar da ampla utilização em processos cicatriciais, há controvérsia sobre a eficácia da terapia na cicatrização cutânea. O objetivo desse estudo foi quantificar e comparar a concentração dos fatores TGF-β1 e PDGF-BB no PRP, plasma sanguíneo e pele, durante diferentes fases do processo de cicatrização da pele tratada ou não com PRP. Foram utilizados sete equinos machos castrados, mestiços, hígidos, com idade entre 16 e 17 (16,14±0,63) anos. Três lesões em formato quadrangular (6,25cm²) foram produzidas cirurgicamente nas regiões glúteas direita e esquerda de todos os animais. Doze horas após indução das feridas, 0,5mL do PRP foi administrado em cada uma das quatro extremidades das feridas de uma das regiões glúteas (Grupo tratado = GT), escolhida aleatoriamente. A região contralateral foi utilizada como controle (GC). As feridas foram submetidas à limpeza diária com água Milli Q, e amostras foram obtidas mediante biópsias realizadas com Punch de 6mm. Foram obtidas seis biópsias de pele, sendo a primeira realizada logo após a produção da ferida (T0), e as demais com 1 (T1) 2 (T2) 7 (T3) e 14 (T4) dias após a indução da lesão. A sexta biópsia (T5) foi obtida após completo fechamento da pele, que ocorreu aproximadamente aos 37 dias (36,85±7,45, GC; 38,85±6,46, GT). Também foram obtidas amostras de sangue com EDTA em todos os tempos mencionados. A quantificação dos fatores de crescimento TGF-β1 e PDGF-BB na pele, PRP e plasma sanguíneo foi realizada pela técnica ELISA. Os dados foram analisados estatisticamente pelo teste t, correlação de Pearson e regressão, utilizando nível de significância de 5%. Não houve diferença entre os grupos, nos valores dos dois fatores de crescimento mensurados na pele, nos diferentes tempos. Também não houve correlação entre a quantidade dos fatores de crescimento presentes na pele e no plasma. Por outro lado, correlação positiva foi observada entre PRP e pele no grupo tratado, para os fatores de crescimento TGF-β1 (r=0,31) e PDGF-BB (r=0,38), bem como entre ambos os fatores de crescimento presentes no PRP (r=0,81). Considerando as concentrações dos fatores de crescimento no T0, os maiores valores cutâneos (p<0,05) do TGF-β1, em ambos os grupos, ocorreram nos tempos T3 e T5. Valores mais elevados (p<0,05) do PDGF-BB ocorreram no T4 (GT) e T5 (GC). No plasma não houve alteração nas concentrações desses fatores em relação ao T0, o que sugere que o PRP não acarreta efeito sistêmico, quando os procedimentos adotados na presente pesquisa são utilizados. A administração local de PRP no volume estudado, 12 h após indução cirúrgica de ferida cutânea na região glútea de equinos não ocasiona maiores concentrações dos fatores de crescimento TGF-β1 e PDGF-BB no plasma sanguíneo e pele, durante o processo de cicatrização

First Sagittarius A* Event Horizon Telescope results. I. The shadow of the supermassive black hole in the center of the Milky Way

Galaxie

First Sagittarius A* event horizon telescope results. II. EHT and multiwavelength observations, data processing, and calibration

Instrumentatio

Probing quantum gravity with elastic interactions of ultrahigh-energy neutrinos

The next generation of radio telescopes will be sensitive to low-scale quantum gravity by measuring ultrahigh-energy neutrinos. In this work, we demonstrate for the first time that neutrino-nucleon soft interactions induced by TeV-scale gravity would significantly increase the number of events detected by the IceCube-Gen2 radio array in the EeV regime. However, we show that these experiments cannot measure the total cross section using only the angular and energy information of the neutrino flux, unless assumptions on the underlying inelasticity distribution of neutral interactions are made.A. G.acknowledges support from the European Union’s H2020-MSCA Grant Agreement No. 101025085. D. G. and M. H. R. are supported in part by US DOE Grant No. DE-SC-0010113. C. A. A. is supported by the Faculty of Arts and Sciences of Harvard University and the Alfred P. Sloan Foundation

Data release for: Solar Atmospheric Neutrinos and the Sensitivity Floor for Solar Dark Matter Annihilation Searches

This is data relating to the paper entitled Data Release for Solar Atmospheric Neutrinos and the Sensitivity Floor for Solar Dark Matter Annihilation Searches

Combining sterile neutrino fits to short-baseline data with IceCube data

Recent global fits to short-baseline neutrino oscillation data have been performed finding preference for a sterile neutrino solution (3+1) over null. In the most recent iteration, it was pointed out that an unstable sterile neutrino (3+1+decay) may be a better description of the data. This is due to the fact that this model significantly reduces the tension between appearance and disappearance datasets. In this work, we add a 1-year IceCube dataset to the global fit obtaining new results for the standard 3+1 and 3+1+decay sterile neutrino scenarios. We find that the 3+1+decay model provides a better fit than the 3+1, even in the presence of IceCube, with reduced appearance to disappearance tension. The 3+1+decay model is a 5.4σ improvement over the null hypothesis and a 2.8σ improvement over the standard 3+1 model.NSF (Grant no. GRFP-1122374)NSF (Grant no. PHY-1707971)NSF (Grant no. PHY-1801996